Jacqueline Hewson

Smith Square, London SW1P
London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Antibody correlates of protection from SARS-CoV-2 reinfection prior to vaccination: A nested case-control within the SIREN study.

Antibody correlates of protection from SARS-CoV-2 reinfection prior to vaccination: A nested case-control within the SIREN study.

Journal: The Journal of infection

Published: August 25, 2022

Immune boosting by B.1.1.529 (Omicron) depends on previous SARS-CoV-2 exposure.

Immune boosting by B.1.1.529 (Omicron) depends on previous SARS-CoV-2 exposure.

Journal: Science (New York, N.Y.)

Published: June 14, 2022

Implementation and Extended Evaluation of the Euroimmun Anti-SARS-CoV-2 IgG Assay and Its Contribution to the United Kingdom's COVID-19 Public Health Response.

Implementation and Extended Evaluation of the Euroimmun Anti-SARS-CoV-2 IgG Assay and Its Contribution to the United Kingdom's COVID-19 Public Health Response.

Journal: Microbiology spectrum

Published: February 24, 2022

Protection against SARS-CoV-2 after Covid-19 Vaccination and Previous Infection.

Protection against SARS-CoV-2 after Covid-19 Vaccination and Previous Infection.

Journal: The New England journal of medicine

Published: February 16, 2022

Pfizer-BioNTech and Oxford AstraZeneca COVID-19 vaccine effectiveness and immune response amongst individuals in clinical risk groups.

Pfizer-BioNTech and Oxford AstraZeneca COVID-19 vaccine effectiveness and immune response amongst individuals in clinical risk groups.

Journal: The Journal of infection

Published: December 22, 2021

Serological profile of first SARS-CoV-2 reinfection cases detected within the SIREN study.

Serological profile of first SARS-CoV-2 reinfection cases detected within the SIREN study.

Journal: The Journal of infection

Published: September 24, 2021

Sociodemographic disparities in COVID-19 seroprevalence across England in the Oxford RCGP primary care sentinel network.

Sociodemographic disparities in COVID-19 seroprevalence across England in the Oxford RCGP primary care sentinel network.

Journal: The Journal of infection

Published: May 22, 2021

Author Correction: Robust SARS-CoV-2-specific T cell immunity is maintained at 6 months following primary infection.

Author Correction: Robust SARS-CoV-2-specific T cell immunity is maintained at 6 months following primary infection.

Journal: Nature immunology

Published: May 21, 2021

Impact of COVID-19 vaccination program on seroprevalence in blood donors in England, 2021.

Impact of COVID-19 vaccination program on seroprevalence in blood donors in England, 2021.

Journal: The Journal of infection

Published: April 27, 2021

Robust SARS-CoV-2-specific T cell immunity is maintained at 6 months following primary infection.

Robust SARS-CoV-2-specific T cell immunity is maintained at 6 months following primary infection.

Journal: Nature immunology

Published: November 01, 2020

Showing 1-10 of 10

Last Updated: 09/26/2026